Impax Asset Management Group
CVS icon

Impax Asset Management Group’s CVS Health CVS Stock Holding History

Impax Asset Management Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-379,107
Closed -$25.7M – 289
2025
Q1 		$25.7M Sell
379,107
-61,872
-14% -$3.7M 0.15% 99
2024
Q4 		$19.8M Sell
440,979
-19,049
-4% -$1.07M 0.09% 124
2024
Q3 		$28.9M Sell
460,028
-40,300
-8% -$2.35M 0.11% 111
2024
Q2 		$29.5M Sell
500,328
-159,100
-24% -$9.95M 0.12% 110
2024
Q1 		$52.6M Sell
659,428
-73,677
-10% -$5.63M 0.2% 95
2023
Q4 		$57.9M Sell
733,105
-1,982
-0.3% -$141K 0.23% 87
2023
Q3 		$51.3M Sell
735,087
-46,768
-6% -$3.31M 0.23% 89
2023
Q2 		$54M Sell
781,855
-67,200
-8% -$4.78M 0.22% 92
2023
Q1 		$63.1M Buy
849,055
+235,126
+38% +$19.7M 0.26% 88
2022
Q4 		$57.2M Buy
613,929
+179,937
+41% +$17.4M 0.26% 90
2022
Q3 		$41.4M Sell
433,992
-7,347
-2% -$727K 0.21% 94
2022
Q2 		$40.9M Sell
441,339
-2,329
-0.5% -$227K 0.2% 93
2022
Q1 		$44.9M Buy
443,668
+7,060
+2% +$742K 0.19% 93
2021
Q4 		$45M Sell
436,608
-86,753
-17% -$8.02M 0.16% 92
2021
Q3 		$44.4M Buy
523,361
+62,525
+14% +$5.24M 0.18% 89
2021
Q2 		$38.5M Buy
460,836
+55,957
+14% +$4.58M 0.17% 89
2021
Q1 		$30.5M Buy
404,879
+215,471
+114% +$15.7M 0.16% 90
2020
Q4 		$12.9M Buy
189,408
+153,408
+426% +$9.98M 0.08% 111
2020
Q3 		$2.1M Buy
36,000
+1,229
+4% +$76.5K 0.02% 196
2020
Q2 		$2.26M Buy
34,771
+970
+3% +$61.1K 0.02% 194
2020
Q1 		$2M Buy
33,801
+5,662
+20% +$378K 0.03% 194
2019
Q4 		$2.09M Buy
28,139
+2,461
+10% +$173K 0.02% 195
2019
Q3 		$1.62M Buy
25,678
+2,544
+11% +$151K 0.02% 195
2019
Q2 		$1.26M Buy
23,134
+2,526
+12% +$136K 0.02% 196
2019
Q1 		$1.11M Buy
20,608
+3,844
+23% +$237K 0.02% 224
2018
Q4 		$1.1M Buy
16,764
+3,358
+25% +$251K 0.02% 204
2018
Q3 		$1.05M Buy
+13,406
New +$958K 0.02% 215

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Impax Asset Management Group's CVS Position: Q2 2025 in Review

Impax Asset Management Group sold out of CVS Health (CVS) in Q2 2025, closing a stake of 379,107 shares — an estimated $25.7M sold.

Impax Asset Management Group first reported a position in CVS in Q3 2018 and held it in 27 quarters. The position peaked at $63.1M in Q1 2023. 1,760 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Impax Asset Management Group reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • Impax Asset Management Group sold 379,107 CVS Health shares in Q2 2025, an estimated $25.7M.
  • Impax Asset Management Group first reported a position in CVS Health in Q3 2018 and held it in 27 quarters.
  • Impax Asset Management Group's CVS Health position peaked at $63.1M in Q1 2023.
  • 1,760 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Impax Asset Management Group's 13F filing for Q2 2025, filed 8 Aug 2025.